The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological evaluation.
The platform can help to align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of cardiovascular autoimmune treatment programs include personalized development, usually drug therapy, rehabilitation interventions, regular follow-up, and multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes depending on the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of autoimmune cardiovascular disease. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.